Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV vs Intracholecystic ICG in Laparoscopic Cholecystectomy
NCT06629415Phase 4Completed
- Sponsor
- Theodor Bilharz Research Institute
- Start
- May 2022
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of indocyanine green in cholecystitis and gallbladder polyp (2 arms), sponsored by Theodor Bilharz Research Institute. Primary endpoint: Rate of better delineation of the biliary tree. Started May 2022; status: completed.
02
Drugs
indocyanine green
03
Conditions
cholecystitisgallbladder polyp
Beyond the preview
Go deeper on NCT06629415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06629415.